Skip to main content

Abstract

This study compares the effects of two Lactobacillus strains, highly adhesive Lactobacillus brevis JCM 1170 (HALB) and less-adhesive Lactobacillus acidophilus JCM 1132 (LALB), on the survival and growth, adhesive gut bacterial communities, immunity, and protection against pathogenic bacterial infection in juvenile hybrid tilapia. During a 5-week feeding trial the fish were fed a diet containing 0 to 10(9) cells/g feed of the two Lactobacillus strains. Samples of intestine, kidney, and spleen were taken at the start and at 10, 20, and 35 days for analysis of stress tolerance and cytokine gene mRNA levels and to assess the diversity of adhesive gut bacterial communities. A 14-day immersion challenge with Aeromonas hydrophila NJ-1 was also performed following the feeding trial. The results showed no significant differences in survival rate, weight gain, or feed conversion in the different dietary treatments. The adhesive gut bacterial communities were strikingly altered in the fish fed either the HALB or the LALB, but the response was more rapid and substantial with the adhesive strain. The two strains induced similar changes in the patterns (upregulation or downregulation) of intestinal, splenic or kidney cytokine expression, but they differed in the degree of response for these genes. Changes in intestinal HSP70 expression levels coincided with changes in the similarity coefficient of the adhesive gut bacterial communities between the probiotic treatments. The highest dose of the HALB appeared to protect against the toxic effects of immersion in A. hydrophila (P < 0.05). In conclusion, the degree to which Lactobacillus strains adhere to the gut may be a favorable criterion in selecting probiotic strain for aquaculture.

Research Insights

SupplementHealth OutcomeEffect TypeEffect Size
Lactobacillus brevis KABP™-052Altered Gut Microbiota CompositionNeutral
Large
Lactobacillus brevis KABP™-052Enhanced Protection Against InfectionBeneficial
Large
Lactobacillus brevis KABP™-052Improved Immune ResponseBeneficial
Moderate
Lactobacillus brevis MAK11L82BAltered Cytokine Gene ExpressionNeutral
Moderate
Lactobacillus brevis MAK11L82BAltered Gut Microbiota CompositionNeutral
Large
Lactobacillus brevis MAK11L82BAltered HSP70 ExpressionNeutral
Moderate
Lactobacillus brevis MAK11L82BEnhanced Protection Against InfectionBeneficial
Large

Pillser helps you make informed health decisions by providing comprehensive, unbiased information about supplements. This includes detailed research on supplement ingredients, their benefits, potential risks, and their overall efficacy. You can contribute by sharing your feedback and suggestions.

Send us an email at support@pillser.com.